Sara Bay Financial Abb Vie Inc. Transaction History

Sara Bay Financial

$276 Billion
Q3 2024

A detailed history of Sara Bay Financial transactions in Abb Vie Inc. stock. As of the latest transaction made, Sara Bay Financial holds 13,382 shares of ABBV stock, worth $2.41 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares

13,382

Previous 13,790 2.96%

Holding current value

$2.41 Million

Previous $2.37 Billion 11.73%

% of portfolio

0.96%

Previous 0.96%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$163.84 - $199.33 $66,846 - $81,326	-408 Reduced 2.96%	13,382 $2.64 Billion
Q2 2024 Jul 19, 2024	BUY	$154.79 - $180.76 $72,132 - $84,234	466 Added 3.5%	13,790 $2.37 Billion
Q1 2024 Apr 16, 2024	BUY	$159.82 - $182.1 $136,965 - $156,059	857 Added 6.87%	13,324 $2.41 Billion
Q4 2023 Jan 12, 2024	BUY	$137.6 - $154.97 $963 - $1,084	7 Added 0.06%	12,467 $1.93 Billion
Q3 2023 Oct 13, 2023	SELL	$133.59 - $154.65 $16,832 - $19,485	-126 Reduced 1.0%	12,460 $1.86 Billion
Q2 2023 Jul 14, 2023	BUY	$132.51 - $164.9 $11,263 - $14,016	85 Added 0.68%	12,586 $1.7 Billion
Q1 2023 Apr 14, 2023	SELL	$144.61 - $166.54 $124,509 - $143,390	-861 Reduced 6.44%	12,501 $1.99 Billion
Q4 2022 Jan 11, 2023	SELL	$138.31 - $165.87 $7,330 - $8,791	-53 Reduced 0.4%	13,362 $2.16 Billion
Q3 2022 Oct 18, 2022	SELL	$134.21 - $153.93 $11,005 - $12,622	-82 Reduced 0.61%	13,415 $1.8 Billion
Q2 2022 Jul 12, 2022	SELL	$137.62 - $174.96 $3,578 - $4,548	-26 Reduced 0.19%	13,497 $2.08 Billion
Q1 2022 Apr 12, 2022	BUY	$131.98 - $163.75 $64,538 - $80,073	489 Added 3.75%	13,523 $2.19 Billion
Q4 2021 Jan 14, 2022	BUY	$107.43 - $135.93 $281,896 - $356,680	2,624 Added 25.21%	13,034 $1.77 Billion
Q3 2021 Oct 08, 2021	BUY	$106.4 - $120.78 $4,894 - $5,555	46 Added 0.44%	10,410 $1.12 Billion
Q2 2021 Jul 16, 2021	BUY	$105.21 - $117.21 $121,517 - $135,377	1,155 Added 12.54%	10,364 $1.17 Billion
Q1 2021 Apr 14, 2021	BUY	$102.3 - $112.62 $246,645 - $271,526	2,411 Added 35.47%	9,209 $997 Million
Q4 2020 Jan 15, 2021	BUY	$80.49 - $108.67 $144,560 - $195,171	1,796 Added 35.91%	6,798 $728 Million
Q3 2020 Oct 07, 2020	BUY	$85.91 - $100.83 $429,721 - $504,351	5,002 New	5,002 $438 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sara Bay Financial, based on Form 13F filings with the SEC.

News

Stay updated on Sara Bay Financial with notifications on news.

Account

Sara Bay Financial Abb Vie Inc. Transaction History